MedPath

A Clinical Study to understand the relationship between Platelet Indices and Sepsis severity in ICU patients

Not Applicable
Conditions
Health Condition 1: R652- Severe sepsis
Registration Number
CTRI/2023/03/051031
Lead Sponsor
DR OREYJEET DAS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

PATIENTS DIAGNOSED WITH SEPSIS (SEVERE INFLAMMATORY RESPONSE SYNDROME WITH A PROVEN OR SUSPECTED SOURCE OF INFECTION)

Exclusion Criteria

1. Patients receiving Platelet transfusions, FFP

2. Patients with Haematological malignancies

3. Patients with ITP, Reactive Thrombocytosis

4. Patients on Immunosuppresants, Anti platelet

drugs

5. Patients with pre-existing autoimmune

condition, on Chemo Therapy and/or Radiation

Therapy

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To correlate the Platelet Indices with SOFA Score and use them as a <br/ ><br> marker to predict the severity of sepsis. <br/ ><br>Timepoint: On Days 1,2,3,4,5 of ICU admission <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To understand which Platelet Indices is/are a better predictor of Sepsis severity <br/ ><br>Timepoint: On Days 1,2,3,4,5 of ICU admission, comparison will be done <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath